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of Tendinopathies in Sport
Spanish Group for Tendon Consensus*†
On October 15, 2016, experts met at Clı́nica CEMTRO in Madrid, Spain, under the patronage of the Spanish Society for Sports
Traumatology (SETRADE), the Spanish Society of Sports Medicine (SEMED), the Spanish Association of Medical Services for
Football Clubs (AEMEF), the Spanish Association of Medical Services for Basketball Clubs (AEMB), F.C. Barcelona, and Clı́nica
CEMTRO. The purpose was to consider the most appropriate clinical management and treatment of tendinopathies in sports,
based on proven scientific data described in the medical literature as well as on each expert’s experience. Prior to the meeting,
each expert received a questionnaire regarding clinical management and treatment of tendinopathies in sports. The present
consensus document summarizes the answers to the questionnaire and the resulting discussion and consensus regarding current
concepts on tendinopathies in sports.
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Tendon injuries are frequent in sports practice, accounting
for between 20% and 30% of all sports injuries. Tendinopa-
thy as a pathological episode may prevent any athlete from
sports participation but has received relatively little
research attention. Only recently has research interest
arisen in the anatomic, biomechanical, and clinical struc-
tures involved in tendinopathy. Treatments have been
based on doctors’ experience, and usual treatment
approaches have entailed anti-inflammatory drugs, physi-
cal therapy, and surgery if conservative treatment was not
sufficient. Knowledge regarding the tendon has been lack-
ing in regard to basic science, anatomy, histology, and bio-
chemistry. A tendon’s response to physical exercise and its
ability to adapt were also previously unknown.
Advances in research on the causes and pathophysiolog-
ical characteristics of tendinopathies have led to various
medical concepts that explain features of tendinopathies
and conditions in which they appear. Tendinopathy studies
are currently guided by 2 main lines of work, led by Cook8-10
in Australia and Alfredson in Sweden,1,2,4,5,21 both of which
have established core concepts concerning physiopathology,
clinical aspects, and treatment approaches. Nevertheless,
treatment approaches among practitioners differ so much
that any comparison is impossible; this, together with the
absence of clearly defined concepts, constrains the ability to
expand our knowledge regarding tendinopathies. Standard
definitions and clearly described concepts are needed.
Thus, we set out to bring together experts in sports ten-
dinopathy with the aim of establishing a precise definition
for each pathological condition and reaching a consensus
regarding clinical and therapeutic factors, in order to pro-
duce a document that can be used as a guide for everyday
clinical practice.
METHODS
Thirty experts in sports traumatology (university profes-
sors, orthopaedic surgeons, and/or sports physicians), all
of whom were medical doctors with more than 15 years of
experience in this specialty and were nationally recognized,
participated in this project. Prior to the meeting, all parti-
cipants received a questionnaire that contained 2 blocks of
questions: a clinical management block and a treatment
block (Appendix).
The questionnaire was prepared, revised, and completed
by the experts themselves. All participants signed a conflict
of interest declaration, and none received economic com-
pensation of any kind from any of the companies that sup-
ported this event.
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On October 15, 2016, the participants met at Clı́nica
CEMTRO in Madrid, Spain, to discuss and reach a consen-
sus for each of the included questions. Levels of consensus
were described as unanimous (100%), highly recommended
(75%-99%), recommended (55%-74%), and controversial
(<55%).
Statistical Analysis
For analysis, participants were grouped as surgeons and
nonsurgeons, with a third group including both. A descrip-
tive analysis was carried out to assess categorical variables,
expressing each as an absolute number or percentage.
Percentages refer, in all cases, to participants.
RESULTS
Clinical Management Block
Analysis of the clinical management block of the question-
naire resulted in the following findings.
Question 1, tendinopathy: 59% considered tendinopathy
present when the tendon was painful and dysfunctional;
24% believed there was a tendinopathy when, additionally,
further tests indicated structural disorders.
Question 2, tendinosis: 43% considered tendinosis pre-
sent when the tendon was painful and dysfunctional and
had structural disorders, whereas 46% considered that ten-
dinosis was not present when there was proof of structural
disorders, whether with pain or not.
Question 3, peritendinitis: 82% defined peritendinitis as
a pathology presenting with pain and inflammation of peri-
tendon and considered it a different concept than tendino-
sis and tendinopathy.
Question 4, acute tendinopathy: 85% considered 6 weeks
as the maximum time since onset of symptoms for tendino-
pathy to be considered acute.
Question 5, chronic tendinopathy: 49% considered such a
condition when symptoms persisted for more than 6 weeks
after their onset, while 31% considered a condition to be
chronic if symptoms persisted for more than 12 weeks.
Question 6, consideration of a possible partial tear: Par-
ticipants agreed unanimously that an abrupt, snaplike,
stabbing onset of pain was a possible indicator of a partial
tendon tear that could later be confirmed by imaging.
Question 7, clinical signs of a peritendinitis: 97% agreed
they would suspect peritendinitis when pinching the ten-
don, sliding it, and moving it were all continuously and
constantly painful and, additionally, when the tendon
showed inflammation, superficial pain, local warmth, red-
ness, crepitation, and swelling.
Question 8, clinical signs of an intratendinous condition:
44% were suspicious of an intratendinous problem if pinch-
ing and sliding the tendon caused variation in pain; 38%
believed there would also be swelling without
inflammation.
Question 9, painless tendinous condition: 89% considered
it to be a coincidental finding, 6% did not treat it, 69%
followed it up, and 26% treated it.
Question 10, further tests: 96% of participants requested
magnetic resonance imaging (MRI) and/or echography.
Echography studies were the most requested imaging test,
chosen by 38% of experts.
Question 11, the use of further tests to determine which
treatment to apply: 43% found echography to be the most
useful additional test, and 11% requested MRI. However,
46% considered either test just as useful.
Question 12, information considered relevant to decide
on a treatment: 57% based their decision on echography
and clinical findings and 26% based their treatment on
clinical, echography, and MRI findings.
Question 13, information considered relevant under ideal
conditions to decide on a treatment: 60% would base their deci-
sion on clinical, echography, and MRI findings and 31% would
base such a decision on clinical and echography findings.
Question 14, the most appropriate definition for a path-
ological neovascularization detected by Doppler echogra-
phy: 64% referred to it as a chronic tendinopathy and 22%
thought a pathological condition was present if there was
an increase in vascularization (Table 1).
Treatment Block
Analysis of the treatment block of the questionnaire
resulted in the following findings.
Question 1: 39% treat pain-free tendinous disorders with
preventive measures to correct any predisposing factors,
and 26% follow them up; 32% also consider MRI and echo-
graphy findings.
Question 2: 29% treat acute tendinopathies with mea-
sures adapted to the biological stage of the repair process,
26% use conservative measures, and 10% allow the condi-
tion to evolve naturally without treating it, simply indicat-
ing pain-free exercises.
Question 3: 69% agree on correcting the cause, predis-
posing factors, and pathological lesions found in echogra-
phy and MRI.
Question 4: 32% apply physical therapy protocols and long-
term strengthening programs (3-4 months) to tendinous
neovascularizations, 14% perform infiltrations with scleros-
ing factors, 11% use high-volume washing procedures, and
14% use surgical or needle percutaneous tenolysis.
Question 5: 31% agree that chronic degenerative intra-
tendinous origins that do not respond to conservative treat-
ment should be treated with percutaneous needle tenotomy
under echography control, 19% believe they should be
TABLE 1
Summary of Results for the Clinical Management Block:
Unanimous and Highly Recommended Answers
Unanimous Highly Recommended
When to suspect a partial
tendon tear
Peritendinitis concept







Evaluation based on clinical
findings and image tests
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treated with surgical scarifications, and 10% believe they
should be treated with shock waves.
Question 6: 22% treat peritendinitis mainly with infiltra-
tions, 19% use topical treatments and manual therapy, and
17% use active physical therapy.
Question 7: 37% would treat full-length diffused tendino-
pathy with active physical therapy (therapeutic exercises),
21% would use topical treatments and manual therapy, and
9% would consider surgery indicated.
Question 8: 36% would apply active physical therapy to
insertion tendinopathies, 22% would use a topical treatment
with manual therapy, and 21% would apply shock waves.
Question 9: 87% would consider surgery to be indicated
in injuries that cannot be treated conservatively or do not
respond to conservative treatment after 24 weeks; in inju-
ries that entail partial tendon ruptures that affect more
than 25% of the tendon diameter; in total tendon ruptures
with functional insufficiency; and when conservative treat-
ment does not allow athletes to return to play.
Question 10: 96% would use orthobiologic products (eg,
enzymes, inflammation regulators, collagen) to treat acute
and chronic tendinopathies, to treat peritendinitis, and as
additional treatment in conjunction with invasive or surgi-
cal treatments.
Question 11: 28% would use platelet-rich plasma (PRP)
to treat chronic tendinopathies, 23% would use it as addi-
tional treatment in conjunction with invasive or surgical
treatments, and 19% do not believe it should be used.
Question12:During thepreseason,31% performbiomechan-
ical studies, analytical metabolic studies, specific strengthening
programs, and preventive physical therapy, all according to
individual needs; 50% would also apply further measures.
Question 13: During the season, 32% apply physical ther-
apy techniques combined with other methods, 23% use
physical therapy techniques only, and 14% use eccentric
tendon exercises.
Question 14: 20% use the disappearance of pain as an
exclusive return-to-play criterion; 39% use functional crite-
ria such as mobility and pain-free strength; and 17% use a
combination of disappearance of pain, normalization of
structures as seen in echography imaging, time criteria
(elapsed time from injury onset to moment of decision), and
other functional criteria previously mentioned (Table 2).
DISCUSSION
Clinical Management Block
The first concepts to be debated during the consensus ses-
sion were definitions for the different types of
tendinopathies, aspects that have been under continuous
evolution since the 1990s.17,22 This first step is essential,
since it allows us to identify pathological entities on which
to base therapeutic indications and so compare results for
different treatments. Both surgeons and nonsurgeons con-
sider a tendinopathy to be present when the affected tendon
is painful and dysfunctional, with or without loss of mus-
cular strength. We did not consider overload as a cause of
injury, as other authors have,20,23 or biochemical findings.3
The term tendinosis refers to any tendinopathy showing
structural alterations, with or without pain, thus requiring
imaging studies such as echography,6 sonoelastography,16
or MRI.19 The diagnosis of tendinosis is thus an issue in
everyday practice because of the need for an imaging test.
In contrast to tendinosis, peritendinitis has been defined as
a condition that is diagnosed by the presence of inflamma-
tion and pain at the peritendon, regardless of other symp-
toms such as crepitation11 or calcareous deposits.18
Definitions of acute and chronic tendinopathy were also
discussed, the consensus being that pain lasting 4 weeks
indicates an acute tendinopathy and pain lasting more than
6 weeks indicates a chronic tendinopathy.
Participants said that if an athlete reported having felt a
snap with an abrupt onset of pain while practicing sport,
they would consider it a partial tendon rupture and would
try to confirm with a specific imaging test (echography or
MRI). It was also generally accepted that availability of
such means of diagnosis would depend on the exact injury,
the location of the injured tendon, and the clinician’s place
of work (eg, hospital, sports club).12,14,16,19
Participants discussed difficulties in diagnosing an
intratendinous condition (tendinopathy) especially when
differentiating the diagnosis of an extratendinous condition
(peritendinitis), due to the specific anatomic features and
locations of some tendons that do not allow for certain tests
to be performed. Such circumstances force physicians to
rely on clinical signs such as surface pain, local warmth,
or redness of the affected area.
Opinions differ regarding tendinous disorders in
pain-free athletes,7,13,15 and such disorders are often
asymptomatic coincidental findings that physicians come
across during their exploration. Expert experience shows
that when symptom-free conditions that do not hinder ath-
letes’ performance are treated, the treatment itself can actu-
ally diminish athletes’ performance, perhaps due to
psychological factors. Current consensus thus indicates that
such findings should not be treated but should be followed up.
Recommendations for additional tests will depend on
the athlete’s situation (eg, sports club, competition) at the
time of injury, the quality of technical equipment avail-
able, and the experience of the physician reviewing the
images, especially considering that some imaging results
(such as echography) are operator-dependent and may
influence the diagnosis.
Experts refer to clinical symptoms and physical exami-
nation of the athlete, together with echography findings
(if available), as the most useful way of diagnosing the con-
dition and obtaining information upon which to base treat-
ment. However, under ideal conditions, MRI complemented
with ultrasonography is considered the best way to
TABLE 2
Summary of Results for the Treatment Block:
Unanimous and Highly Recommended Answers
Unanimous Highly Recommended
No answers Surgery indicated
Use of orthobiologic products
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precisely diagnose a tendinopathy. Doppler echography is
used to verify pathological neovascularization when
chronic tendinopathies are detected, which does not corre-
spond to a revascularization in a tendon’s normal healing
stages.
Experts are far from reaching a consensus on the use of
diagnostic imaging in painful tendinopathies, for rehabili-
tation monitoring, or to assess treatment response.
Treatment Block
When assisting a patient with a pain-free tendinous disor-
der, many experts consider it useful to correct predisposing
factors, yet there are differences between surgeons and
nonsurgeons: Surgeons prefer to simply follow up, while
nonsurgeons apply preventive measures for predisposing
factors. Experts strongly recommended that imaging stud-
ies be used to identify predisposing factors, although opin-
ion differed between surgeons and nonsurgeons with
regard to the athlete’s and physician’s available resources
at their training/work sites.
Regarding acute tendinopathies, participants achieved
consensus that treatment should depend on the biological
repair stage of the tendon. There is no one-size-fits-all stan-
dard treatment, as can be seen from Table 3.
In chronic tendinopathies, experts recommended addres-
sing the cause of the tendinopathy, with emphasis on pre-
disposing factors. Additionally, possible treatments for
injuries found on MRI and echography should always be
kept in mind.
Chronic tendinous neovascularizations should always
be treated, and chronic tendinopathies should be treated
depending on the location of the affected tendon. No con-
sensus was reached as to the most appropriate treatment
(Table 4).
There was no consensus on how to treat degenerative
intratendinous origins, although discussions indicated that
such treatment should include percutaneous needle teno-
tomies under echographic control, and open surgery should
be considered in certain cases.
It is difficult to decide on a treatment for peritendinitis,
because it is essential to first distinguish it from a teno-
synovitis. Infiltration is the preferred treatment for peri-
tendinitis. Conservative treatment should be applied
within the first 2 weeks after minor injuries.
In diffused tendinopathies that affect the entire tendon
length, active physical therapy with therapeutic exercises
is recommended. Insertional tendinopathies will likewise
be treated with therapeutic exercises, surgery not being
generally indicated.
Surgery is the preferred treatment in tendinopathies
that are resilient to conservative treatment of more than
24 weeks, in partial tears that affect more than 25% of the
total tendon diameter, in total tendon tears with functional
alterations, and in any other tendinopathy that prevents
the athlete from playing, despite conservative treatment.
Orthobiologic products are strictly linked to the biologi-
cal stage of the tendinopathy at the moment of application
and may be used as a complement to applied treatments.
Use of PRP still presents many uncertainties. The health
care community must carefully examine any scientific evi-
dence as well as all literature mentioning such treatments.
If PRP is used, it must always be given via peritendinous
administration and never intratendinous due to the risk of
secondary tendon tear.
In preseason stages, it is advisable for all athletes to
undergo biomechanical studies and metabolic analysis.
They should also perform preventive strength conditioning
programs in combination with relative rest periods.
Once athletes are in season, or during maximum load
periods, experts strongly recommended isometric, concen-
tric, and plyometric exercises and physical therapy tech-
niques (cryotherapy, massage, use of straps).
When advising athletes on return to play, experts con-
sider individually based objective criteria concerning pain
and exercise tolerance.
In summary, the participants had a higher degree of con-
sensus when defining pathological entities from the clinical
management block. A certain degree of controversy was found
TABLE 3






Conservative physical therapy 26 26 27








Isometric exercises 7 4 8
Concentric exercises 3 4 2
Eccentric exercises 10 9 10
Other 7 4 8
Specify a combination of your
choice
8 9 8
aValues are expressed as percentages.
TABLE 4
Frequency Distribution for Indicated Treatments
of Neovascularizationsa
General Surgeons Nonsurgeons
Sclerosing factor infiltration 14 14 13




Corticoid infiltration 0 0 0
No treatment 7 14 3




Other 23 14 27
aValues are expressed as percentages.
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in the treatment block since there is no golden, one-size-fits-
all therapeutic approach. Furthermore, depending on the
availability of diagnostic tests and the conditions under which
athletes trainand compete, certain treatmentsaremore likely
to be therapeutically indicated. Last, surgeons’ and nonsur-
geons’ points of view varied regarding all of the above.
Further studies and consensus sessions are necessary in
translational medicine, with the aim of adapting treat-
ments to each tendon pathology.
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Guillermo Álvarez Rey, MD (Medical Director at AMS
Exercise Medical Center, Málaga, Spain); Francisco
Angulo, MD (President of the Spanish Association for
Football Clubs Medical Services [AEMEF], Spain); Jordi
Ardevol Cuesta, MD (SETRADE President, Chief of
Surgery Unit, Hospital ASEPEYO Sant Cugat, Clı́nica
Diagonal Trauma Unit, Barcelona, Spain); Rafael Arriaza
Loureda, MD (Arriaza y Asociados Medical Institute,
Hospital HM Modelo, La Coruña, Spain); Fernando Ávila
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1. Do you believe tendinopathy is present when
a. There is both tendon pain and dysfunction?
b. It is exclusively associated with tendon pain?
c. It is exclusively associated with dysfunction?
d. Option a is present with structural disorders?
e. Option a is present with no structural disorders?
f. Just structural disorders are present, with or without pain?
g. Other combinations (specify)
2. Do you believe tendinosis is present when
a. There is both tendon pain and dysfunction?
b. It is exclusively associated with tendon pain?
c. It is exclusively associated with dysfunction?
d. Option a is present with structural disorders?
e. Option a is present with no structural disorders?
f. Just structural disorders are present, with or without pain?
g. Other combinations (specify)
3. Do you believe peritendinitis is present when
a. There is inflammation of the peritendon?
b. The peritendon is painful?
c. Peritendinitis is a different concept than tendinosis.
d. Peritendinitis is a different concept than tendinopathies.
e. All of the above.
f. None of the above.
g. Other combinations (specify).
4. From the onset of pain, how long would a tendinopathy need to
last to be considered acute?
a. 2 more weeks
b. 6 more weeks
c. 12 more weeks
d. 24 more weeks




5. From the onset of pain, how long would a tendinopathy need to
last to be considered chronic?
a. 2 more weeks
b. 6 more weeks
c. 12 more weeks
d. 24 more weeks
6. If pain appears suddenly, with a snap or a stab, would you
consider it a possible partial tear?
a. I would
b. I would not
c. I would, if I can confirm with imaging
7. Which clinical signs would make you consider a peritendinitis?
a. Pinching and sliding maneuver causes constant pain
b. There is inflammation: superficial pain, warm to the touch,
redness, crepitation, and swelling
c. a and b
d. None of the above
8. Which clinical signs would make you suspect an intratendi-
nous condition?
a. Pinching and sliding maneuver causes pain to increase and
decrease
b. Inflammation-free swelling: superficial pain, warmth,
redness, and crepitation
c. a and b
d. Neither a nor b
9. Regarding painless tendinous conditions, how do you address
such findings?
a. I consider it a causal finding and apply no treatment.
b. I consider it a causal finding and follow it up.
c. I consider it a causal finding and treat it.
d. I neither consider it nor treat it.





e. b and c
f. Other, specify
11. Which further tests do you consider most useful in order to





e. b and c
f. Other
12. In your daily clinical practice, in order to decide on a treat-
ment, which data do you consider relevant?
a. Clinical: onset history, exploration
b. MRI findings
c. Echography findings
d. a and b
e. a and c
f. b and c
g. a, b, and c
13. Under ideal conditions, in order to decide on a treatment,
which data would you consider relevant?
a. Clinical: onset history, exploration
b. MRI findings
c. Echography findings
d. a and b
e. a and c
f. b and c
g. a, b, and c
14. Which do you consider the most appropriate definition for a
pathological neovascularization detected by Doppler
echography?
a. Hypervascularization in a chronic tendinopathy.
b. Hypervascularization in an acute tendinopathy.
c. Any kind of increase in vascularization.
d. Hypervascularization after an injury.
Treatment Block
1. When I encounter a pain-free tendinous disorder, I address it
a. According to the findings from the echography and the MRI
b. By doing nothing
c. By applying preventive measures that correct any
predisposing factor
d. By following it up
e. a, c, and d
2. I treat acute tendinopathies with
a. Measures adapted to the biological stage of the repair process
b. Conservative physical therapy
c. No intervention, allowing it to progress with pain-free
activity





i. Specify your own treatment
3. Treatments for chronic tendinopathy should correct
a. The cause
b. Predisposition factors
c. Pathological injury findings from echography and MRI
d. a and b
e. a and c
f. a, b, and c
g. Other combinations
4. What kind of direct approach do you think tendinous neovas-
cularizations should be treated with?
a. Infiltration including sclerosing factors
b. High-volume local infiltration
c. Surgical or needle percutaneous tenolysis
d. Corticoid infiltration
e. I do not treat it
f. Physical therapy protocol and long-term strengthening
program (3-4 months)
g. Other
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Treatment Block
5. What kind of direct approach should be used for chronic
degenerative intratendinous origins when they do not respond
to conservative treatment?
a. Percutaneous needle tenotomies under echography control
b. Shock waves
c. Surgical scarification
d. Invasive electrotherapeutic techniques
e. No treatment applied
f. Other
6. How do you believe peritendinitis should be treated?
a. Active physical therapy (therapeutic workout)




f. Other: specify which or combinations
7. How should a diffused tendinopathy be treated when the whole
tendon length is affected?
a. Active physical therapy (therapeutic workout)
b. Topic treatment, manual therapies
c. Surgery
d. Shock waves
e. Other electrotherapy treatments
f. Systemic treatment
8. How should insertion tendinopathies be treated?
a. Active physical therapy (therapeutic workout)
b. Topical treatment, manual therapies
c. Surgery
d. Shock waves
e. Other electrotherapy treatments
f. Systemic treatment
9. When are surgical procedures indicated?
a. When faced with pathological injuries that cannot be treated
conservatively
b. When conservative treatment has failed for more than 24
weeks
d. Partial tendon ruptures that affect more than 25% of tendon
diameter
e. Total tendon ruptures with functional insufficiency
f. When athletes are unable to play despite conservative
treatment
g. All of the above
h. None
i. Other
10. When is the use of orthobiologic products (enzymes, inflam-




d. As additional treatment to invasive or surgical treatments
e. All of the above
f. None
g. Other





d. As additional treatment to invasive or surgical treatments
e. All of the above
f. None
g. Other
12. Which preventive measures do you apply during the preseason?
a. Biomechanical study
b. Blood test for metabolic study
c. Specific strengthening program
d. Preventive physical therapy: loosening up
e. All of the above
f. None
g. Other combinations





e. Loosening up physical therapy (cryotherapy, massage, use
of straps)
f. All of the above
g. None
h. Other combinations
14. Which criteria do you follow when considering return to play?
a. Disappearance of pain
b. Structure normalization as seen in echography
c. Time-based criteria: time elapsed since injury
d. Functional criteria, mobility, pain-free strength
e. All the above
f. None
g. Other combinations
aMRI, magnetic resonance imaging.
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